Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Medicenna Therapeutics Q1 EPS $(0.07) Misses $(0.06) Estimate

Medicenna Therapeutics (NASDAQ:MDNA) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 30 percent increase over losses of $(0.10) per share
byBenzinga Newsdesk
August 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Medicenna Therapeutics (NASDAQ:MDNA) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 30 percent increase over losses of $(0.10) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Rapid7: Q4 Earnings Insights

By Benzinga Insights
Today, 9:26 AM
Rapid7 (NASDAQ:RPD) reported its Q4 earnings results on Wednesday, February 9, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Rapid7 reported in-line EPS of $-0.16 versus an estimate of $-0.16.

RPD